174 related articles for article (PubMed ID: 21133853)
41. Intracellular CD24 disrupts the ARF-NPM interaction and enables mutational and viral oncogene-mediated p53 inactivation.
Wang L; Liu R; Ye P; Wong C; Chen GY; Zhou P; Sakabe K; Zheng X; Wu W; Zhang P; Jiang T; Bassetti MF; Jube S; Sun Y; Zhang Y; Zheng P; Liu Y
Nat Commun; 2015 Jan; 6():5909. PubMed ID: 25600590
[TBL] [Abstract][Full Text] [Related]
42. CARF binds to three members (ARF, p53, and HDM2) of the p53 tumor-suppressor pathway.
Kamrul HM; Wadhwa R; Kaul SC
Ann N Y Acad Sci; 2007 Apr; 1100():312-5. PubMed ID: 17460193
[TBL] [Abstract][Full Text] [Related]
43. Deregulation of the TP53/p14ARF tumor suppressor pathway in low-grade diffuse astrocytomas and its influence on clinical course.
Watanabe T; Katayama Y; Yoshino A; Komine C; Yokoyama T
Clin Cancer Res; 2003 Oct; 9(13):4884-90. PubMed ID: 14581362
[TBL] [Abstract][Full Text] [Related]
44. ARF tumor suppression in the nucleolus.
Maggi LB; Winkeler CL; Miceli AP; Apicelli AJ; Brady SN; Kuchenreuther MJ; Weber JD
Biochim Biophys Acta; 2014 Jun; 1842(6):831-9. PubMed ID: 24525025
[TBL] [Abstract][Full Text] [Related]
45. Nucleophosmin (B23) targets ARF to nucleoli and inhibits its function.
Korgaonkar C; Hagen J; Tompkins V; Frazier AA; Allamargot C; Quelle FW; Quelle DE
Mol Cell Biol; 2005 Feb; 25(4):1258-71. PubMed ID: 15684379
[TBL] [Abstract][Full Text] [Related]
46. p53 gene status and expression of p53, MDM2, and p14 proteins in ameloblastomas.
Kumamoto H; Izutsu T; Ohki K; Takahashi N; Ooya K
J Oral Pathol Med; 2004 May; 33(5):292-9. PubMed ID: 15078490
[TBL] [Abstract][Full Text] [Related]
47. Modification of the p53 transgene of a replication-competent adenovirus prevents mdm2- and E1b-55kD-mediated degradation of p53.
Sauthoff H; Pipiya T; Chen S; Heitner S; Cheng J; Huang YQ; Rom WN; Hay JG
Cancer Gene Ther; 2006 Jul; 13(7):686-95. PubMed ID: 16470212
[TBL] [Abstract][Full Text] [Related]
48. Siva1 inhibits p53 function by acting as an ARF E3 ubiquitin ligase.
Wang X; Zha M; Zhao X; Jiang P; Du W; Tam AY; Mei Y; Wu M
Nat Commun; 2013; 4():1551. PubMed ID: 23462994
[TBL] [Abstract][Full Text] [Related]
49. Runt-related transcription factor RUNX3 is a target of MDM2-mediated ubiquitination.
Chi XZ; Kim J; Lee YH; Lee JW; Lee KS; Wee H; Kim WJ; Park WY; Oh BC; Stein GS; Ito Y; van Wijnen AJ; Bae SC
Cancer Res; 2009 Oct; 69(20):8111-9. PubMed ID: 19808967
[TBL] [Abstract][Full Text] [Related]
50. Modulation of p53 C-terminal acetylation by mdm2, p14ARF, and cytoplasmic SirT2.
van Leeuwen IM; Higgins M; Campbell J; McCarthy AR; Sachweh MC; Navarro AM; Laín S
Mol Cancer Ther; 2013 Apr; 12(4):471-80. PubMed ID: 23416275
[TBL] [Abstract][Full Text] [Related]
51. p14ARF inhibits the growth of p53 deficient cells in a cell-specific manner.
Li Y; He L; Bruce A; Parihar K; Ingram A; Liu L; Tang D
Biochim Biophys Acta; 2006 Aug; 1763(8):787-96. PubMed ID: 16764954
[TBL] [Abstract][Full Text] [Related]
52. Physical and functional interaction of the p14ARF tumor suppressor with ribosomes.
Rizos H; McKenzie HA; Ayub AL; Woodruff S; Becker TM; Scurr LL; Stahl J; Kefford RF
J Biol Chem; 2006 Dec; 281(49):38080-8. PubMed ID: 17035234
[TBL] [Abstract][Full Text] [Related]
53. Significance of MDM2 and P14 ARF polymorphisms in susceptibility to differentiated thyroid carcinoma.
Zhang F; Xu L; Wei Q; Song X; Sturgis EM; Li G
Surgery; 2013 May; 153(5):711-7. PubMed ID: 23218882
[TBL] [Abstract][Full Text] [Related]
54. Post-translational Down-regulation of Melanoma Antigen-A11 (MAGE-A11) by Human p14-ARF Tumor Suppressor.
Minges JT; Grossman G; Zhang P; Kafri T; Wilson EM
J Biol Chem; 2015 Oct; 290(41):25174-87. PubMed ID: 26330556
[TBL] [Abstract][Full Text] [Related]
55. Dual action of the adenovirus E1A 243R oncoprotein on the human proliferating cell nuclear antigen promoter: repression of transcriptional activation by p53.
Kannabiran C; Morris GF; Mathews MB
Oncogene; 1999 Dec; 18(54):7825-33. PubMed ID: 10618724
[TBL] [Abstract][Full Text] [Related]
56. [Hepatitis B virus X protein inhibits hepatoma cell growth in vitro through p14(ARF)-dependent and p14(ARF)-independent pathways].
Yu DH; Lin J; Qu JH; Zhu Z; Li FM; Ni CR; Zhu MH
Nan Fang Yi Ke Da Xue Xue Bao; 2009 Jun; 29(6):1089-93. PubMed ID: 19726330
[TBL] [Abstract][Full Text] [Related]
57. Mdm2 regulates p53 independently of p19(ARF) in homeostatic tissues.
O'Leary KA; Mendrysa SM; Vaccaro A; Perry ME
Mol Cell Biol; 2004 Jan; 24(1):186-91. PubMed ID: 14673154
[TBL] [Abstract][Full Text] [Related]
58. Evidence that proteasome-dependent degradation of the retinoblastoma protein in cells lacking A-type lamins occurs independently of gankyrin and MDM2.
Nitta RT; Smith CL; Kennedy BK
PLoS One; 2007 Sep; 2(9):e963. PubMed ID: 17896003
[TBL] [Abstract][Full Text] [Related]
59. Regulation of Myc function by ARF: checkpoint for Myc-induced oncogenesis.
Sarkar D; Fisher PB
Cancer Biol Ther; 2006 Jun; 5(6):693-5. PubMed ID: 16775430
[TBL] [Abstract][Full Text] [Related]
60. AKT regulates NPM dependent ARF localization and p53mut stability in tumors.
Hamilton G; Abraham AG; Morton J; Sampson O; Pefani DE; Khoronenkova S; Grawenda A; Papaspyropoulos A; Jamieson N; McKay C; Sansom O; Dianov GL; O'Neill E
Oncotarget; 2014 Aug; 5(15):6142-67. PubMed ID: 25071014
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
